Authors:
ROSENTHAL J
HEALEY T
ELLIS R
GILLAN E
CAIRO MS
Citation: J. Rosenthal et al., A 2-YEAR FOLLOW-UP OF NEONATES WITH PRESUMED SEPSIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR DURING THE FIRST WEEK OF LIFE, The Journal of pediatrics, 128(1), 1996, pp. 135-137
Authors:
ROSENTHAL J
ELLIS R
HEALEY T
GILLAN E
CAIRO MS
Citation: J. Rosenthal et al., LONG-TERM (2 YRS) HEMATOLOGIC, IMMUNOLOGICAL, AND DEVELOPMENTAL (HID)FOLLOW-UP OF NEONATES (N) WITH PRESUMED SEPSIS TREATED WITH G-CSF DURING THE 1ST 3 DAYS OF LIFE, Pediatric research, 37(4), 1995, pp. 298-298
Authors:
WILLIAMS S
GILLAN E
SUEN Y
ISHIZAWA L
CAIRO MS
Citation: S. Williams et al., PHOSPHOROTHIOATE C-MYC ANTISENSE OLIGODEOXY-NUCLEOTIDE REDUCES VIABILITY, PROLIFERATION AND C-MYC PROTEIN EXPRESSION IN AN HL-60 MODEL, Journal of cellular biochemistry, 1994, pp. 105-105
Authors:
CAIRO MS
CHRISTENSEN R
SENDER L
ROSENTHAL J
ELLIS R
GILLAN E
AGOSTI J
Citation: Ms. Cairo et al., WILL ADMINISTRATION OF RECOMBINANT GM-CSF TO VERY-LOW-BIRTH-WEIGHT (VLBW) NEONATES (N) DIMINISH NOSOCOMIAL INFECTIONS - RESULTS OF A PHASE-I TRIAL, Pediatric research, 35(4), 1994, pp. 10000294-10000294
Authors:
WEINTHAL J
SENDER L
BRIONES G
GILLAN E
VANDEVEN C
CAIRO MS
Citation: J. Weinthal et al., THE SEQUENTIAL COMBINATION OF GM-CSF FOLLOWED BY G-CSF SIGNIFICANTLY ENHANCES MYELOID ENGRAFTMENT COMPARED TO GM-CSF ALONE FOLLOWING BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000286-10000286